Safety of rolapitant, a novel NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic chemotherapy (MEC or HEC)

被引：2
|
作者：
Urban, Laszlo
Poma, Allen
Dardeno, Michelle Motta
Martell, Robert E.
机构：
[1] Matrahaza Healthcare Ctr, Matrahaza, Hungary
[2] Univ Teaching Hosp, Matrahaza, Hungary
[3] TESARO Inc, Waltham, MA USA
[4] Tufts Med Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.9636
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9636
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of NEPA, a novel combination of netupitant (NETU) and palonosetron (PALO), for prevention of chemotherapy-induced nausea and vomiting (CINV) following highly emetogenic chemotherapy (HEC).
    Hesketh, Paul Joseph
    Rossi, Giorgia
    Rizzi, Giada
    Palmas, Marco
    Alyasova, Anna
    Drobner, Igor
    Gralla, Richard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Takako Inoue
    Madoka Kimura
    Junji Uchida
    Kazumi Nishino
    Toru Kumagai
    Junko Taniguchi
    Fumio Imamura
    International Journal of Clinical Oncology, 2017, 22 : 600 - 604
  • [43] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Inoue, Takako
    Kimura, Madoka
    Uchida, Junji
    Nishino, Kazumi
    Kumagai, Toru
    Taniguchi, Junko
    Imamura, Fumio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 600 - 604
  • [44] Patterns and severity of chemotherapy-induced nausea (CIN) in patients with gastrointestinal cancers associated with highly to moderately emetogenic chemotherapy (HEC and MEC)
    Aiba, Keisuke
    Tamura, Kazuo
    Saeki, Toshiaki
    Baba, Hideo
    Kitagawa, Yuko
    Yoshida, Kazuhiro
    Furuse, Junji
    Kakeji, Yoshihiro
    Wakabayashi, Go
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [45] An oral NK1 antagonist for the prevention of nausea and vomiting induced by highly emetogenic chemotherapy
    Pendergrass, K
    Hargreaves, R
    Petty, KJ
    Carides, AD
    Evans, JK
    Horgan, KJ
    DRUGS OF TODAY, 2004, 40 (10) : 853 - 863
  • [46] Safety of Palonosetron and Ondansetron in Preventing Chemotherapy-induced Nausea and Vomiting in Pediatric Patients Receiving Moderately-or Highly-Emetogenic Chemotherapy
    Kovacs, G.
    Wachtel, A. E.
    Basharova, E. V.
    Spinelli, T.
    Nicolas, P.
    Cipriani, S.
    Kabickova, E.
    DRUG SAFETY, 2014, 37 (10) : 843 - 843
  • [47] The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Veerisa Vimolchalao
    Siwat Sakdejayont
    Ploytuangporn Wongchanapai
    Shama Sukprakun
    Pattama Angspatt
    Wilai Thawinwisan
    Piyachut Chenaksara
    Virote Sriuranpong
    Chanida Vinayanuwatikun
    Napa Parinyanitikun
    Nattaya Poovorawan
    Suebpong Tanasanvimon
    International Journal of Clinical Oncology, 2020, 25 : 396 - 402
  • [48] The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Vimolchalao, Veerisa
    Sakdejayont, Siwat
    Wongchanapai, Ploytuangporn
    Sukprakun, Shama
    Angspatt, Pattama
    Thawinwisan, Wilai
    Chenaksara, Piyachut
    Sriuranpong, Virote
    Vinayanuwatikun, Chanida
    Parinyanitikun, Napa
    Poovorawan, Nattaya
    Tanasanvimon, Suebpong
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 396 - 402
  • [49] Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers
    Navari, R.
    Jordan, K.
    Rapoport, B. L.
    Schnadig, I.
    Chasen, M.
    Arora, S.
    Powers, D.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] ROLAPITANT FOR PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY IN THE UNITED STATES: SUBGROUP ANALYSIS FROM A RANDOMIZED PHASE III TRIAL
    Schwartzberg, L. S.
    Powers, D.
    Arora, S.
    Harrow, B.
    Schnadig, I. D.
    VALUE IN HEALTH, 2016, 19 (03) : A135 - A136
12345